Pharmacy Services Recalls
Voluntary Market Withdrawal: Octagam [Immune Globulin Intravenous (human)] 10 Percent Liquid Preparation]
Oct 23, 2017 1:44 PM
Octapharma USA Inc. is initiating a voluntary market withdrawal of octagam 10% [Immune Globulin Intravenous (human)] 10% Liquid Preparation] that is labeled with lot numbers K724B8541 & K725A8541. Although there have been no reports of serious injury at this time, Octapharma has determined, through consultation with the public health authorities at FDA, the most prudent course of action is to suspend further administration of octagam 10% from these particular production lots.
More on the FDA website: